» Articles » PMID: 32961330

Infection-induced Myeloperoxidase Specific Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Vasculitis: A Systematic Review

Overview
Journal Clin Immunol
Date 2020 Sep 22
PMID 32961330
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We conducted a systematic review to identify cases of infection-induced anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Methods: PubMed/Medline databases were searched from inception to July of 2020, according to PRISMA guidelines.

Results: Among the 618 abstracts identified, 18 articles describing 23 patients (60.9% female, mean age 50.5 years) were included. Median time between infection and vasculitis development was 3 months. Five (21.7%) patients expired during follow-up. Vasculitis regressed after the resolution of infection in 12/23 (52.2%). ANCA titers decreased significantly on follow-up in 14/16 patients and in all survivors in which they were measured. Pathogens reported included Mycobacterium spp., Coccidioides spp., Rickettsia rickettsii, Staphylococcus spp., EBV, CMV and Dengue virus.

Conclusions: MPO-AAV can occur after infection and may regress after its resolution. Infection should be considered in cases of MPO-AAV, as immunosuppressive treatment can have catastrophic results if the infection is not adequately treated.

Citing Articles

Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with silicosis, alveolar hemorrhage, and rapidly progressive glomerulonephritis: a case report.

Mizuhashi K AME Case Rep. 2025; 9:8.

PMID: 39866275 PMC: 11760511. DOI: 10.21037/acr-24-112.


Clinical and pathological features of cerebrospinal meningitis caused by Pantoea agglomerans : a case report.

Li H, Yu J, Zeng Z, Liu C, Zhang Y, Xia H BMC Infect Dis. 2024; 24(1):1150.

PMID: 39396943 PMC: 11472509. DOI: 10.1186/s12879-024-10035-6.


Autoimmune Diseases Following Environmental Disasters: A Narrative Review of the Literature.

Mpakosi A, Cholevas V, Tzouvelekis I, Passos I, Kaliouli-Antonopoulou C, Mironidou-Tzouveleki M Healthcare (Basel). 2024; 12(17).

PMID: 39273791 PMC: 11395540. DOI: 10.3390/healthcare12171767.


The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.

Becker R, Tantry U, Khan M, Gurbel P J Thromb Thrombolysis. 2024; 58(1):15-49.

PMID: 39179952 PMC: 11762605. DOI: 10.1007/s11239-024-03028-4.


Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic.

Dijana P, Marin P, Simac P, Ana V, Katarina B, Katarina G Rheumatol Int. 2024; 44(10):1935-1940.

PMID: 38656608 DOI: 10.1007/s00296-024-05596-3.